Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 1.24% | 165.22 | 0.7% | $1347.13m | |
| LLY | Eli Lilly & Co. | 0.98% | 324.71 | 1.1% | $1078.19m | |
| ABBV | AbbVie, Inc. | 2.04% | 141.14 | 1.9% | $869.64m | |
| PFE | Pfizer Inc. | 0.84% | 44.51 | 0.9% | $804.85m | |
| BMY | Bristol-Myers Squibb Co. | 1.22% | 71.39 | 1.0% | $782.09m | |
| MRK | Merck & Co., Inc. | 0.78% | 88.23 | 0.7% | $715.89m | |
| AZN | AstraZeneca Plc | 2.40% | 56.89 | 1.0% | $396.84m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | -0.77% | 195.27 | 8.2% | $215.71m | |
| GSK | GSK Plc | 2.29% | 30.94 | 0.3% | $214.43m | |
| NVS | Novartis AG | 2.22% | 78.38 | 0.2% | $206.16m | |
| GBT | Global Blood Therapeutics, Inc. | 0.01% | 68.49 | 5.4% | $191.19m | |
| IDXX | IDEXX Laboratories, Inc. | 3.67% | 349.03 | 3.9% | $191.04m | |
| HZNP | Horizon Therapeutics Plc | 1.73% | 65.37 | 5.4% | $176.65m | |
| ATXI | Avenue Therapeutics, Inc. | 20.16% | 13.83 | 0.0% | $167.39m | |
| SRPT | Sarepta Therapeutics, Inc. | -0.84% | 109.02 | 12.4% | $135.59m |
Company Profile
Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. The company was founded by Jack A. Khattar on March 30, 2005 and is headquartered in Rockville, MD.